2008: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's: Clinical Aspects and Therapeutics I
Search or Browse by Day

Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's: Clinical Aspects and Therapeutics I

Sunday, October 26, 2008
544
Exercise-Induced Pulmonary Hypertension Associated Systemic Sclerosis: Four Distinct Entities
545
Course of Modified Rodnan Skin Score in Systemic Sclerosis Clinical Trials: Analysis of 3 Large Multicenter, Randomized Clinical Trials
546
Development Of A Ten-years Mortality Model In Systemic Sclerosis Patients By Different Analytical Approaches
547
Correlations of Δ 6-minute walk distance (6MWD) with Δ Subjective Measures of Dyspnea in Systemic Sclerosis (SSc) Patients
548
Direct, Indirect, and Total Costs Related to Systemic Sclerosis
549
Clinical Characterization of Connective Tissue Diseases Associated Pulmonary Arterial Hypertension from the REVEAL Registry
550
Pain is Associated with Higher Physician Use in Patients with Systemic Sclerosis
551
Serial Anti-RNA-Polymerase Antibody Levels in Patients with Systemic Sclerosis
552
Vascular Injury and Abnormal Type V Collagen Deposition Promote Functional and Architectural Alteration in Pulmonary Systemic Sclerosis
553
Severity and Prognosis of Pulmonary Arterial Hypertension Associated with Connective Tissue Diseases (PAH-CTD) in Comparison to Idiopathic PAH (IPAH)
554
Significant Racial and Gender Differences in Specificity of Scleroderma-related Autoantibodies
555
Clinical Significance of Autoantibodies to Topoisomerase I and RNA polymerase III in an Unselected Rheumatic Disease Population
556
Evolution Of High Resolution Computed Tomography Of The Chest After Autologous Haematopoietic Stem Cell Transplantation In Systemic Sclerosis: Pilot Observations
557
Natural History Of Pulmonary Arterial Hypertension In Systemic Sclerosis: A Late Or Early Complication?
558
Exercise Echocardiograms (EE) in Scleroderma Patients with Different Auto-antibodies
559
Autoantibody Profile of Scleroderma Renal Crisis in Italy
560
Cardiopulmonary Exercise Testing (CPET) detects early pulmonary vasculopathy and defines the etiology of exercise intolerance in patients with Systemic Sclerosis (SScl)
561
Systemic Sclerosis with Diffuse Cutaneous Involvement and Anticentromere Antibody: An Unusual Combination
562
Muscarinic-3 Acetylcholine Receptor Autoantibody in Patients with Systemic Sclerosis
563
Use of Patient Historical Clues to Predict Weekly Raynauds Condition Score Measured by Electronic Digital Diary
564
Proteomic Identification Of Target Antigens Of Antinuclear Antibodies In Systemic Sclerosis Patients
565
Myocardial Fibrosis and Inflammation in Scleroderma: Histopathologic Analysis
566
“PHAROS” - Pulmonary Hypertension (PH) Assessment and Recognition of Outcomes in Systemic Sclerosis (SSc): Pre-Pulmonary Arterial Hypertension (PAH) Preliminary Outcomes
567
Small Bowel Involvement in Systemic Sclerosis
568
Scleroderma Renal Crisis and Thrombotic Thrombocytopenic Purpura - are they Related?
569
Improvement in Tendon Friction Rubs is associated with Skin Softening and Decrease in Functional Disability: Analysis from the D- Penicillamine Study
570
Assessment of Predictive Factors of Progression of Interstitial Lung Disease in Systemic Sclerosis
571
Gastric Antral Vascular Ectasia (GAVE) in early diffuse SSc: Report from the SCOT Trial
572
A Novel Prognostic Rule-Based Scheme Using Capillaroscopy And Autoantibodies For Identifying Raynaud’s Phenomenon Patients At High Risk For The Development Of Systemic Sclerosis
573
Characteristics Of Juvenile Onset Systemic Sclerosis Patients In An Adult Single Centre Cohort
574
Impact Of Digital Ulcers On Disability And Health Related Quality Of Life In Systemic Sclerosis
575
Brain Natiuretic Peptide (BNP): A Marker Of Pulmonary Arterial Hypertension In Systemic Sclerosis Not Influenced By Interstitial Lung Disease
576
Laser Doppler Imaging Quantification of Peripheral Blood Flow at Baseline and After Cold Stimulus in Systemic Sclerosis
577
Malnutirition is Common in Systemic Sclerosis: Results from the Canadian Scleroderma Research Group Database
578
Systemic Sclerosis-associated Myopathies: Prognostic Value Of Muscle Histopathology And Case-control Study Of Clinical And Serological Characteristics
579
Influence Of Age At Disease Onset On Clinical And Immunological Manifestations In Systemic Sclerosis: Analysis Of 1102 Brazilian Patients
580
Impaired Exercise Performance in Systemic Sclerosis. Clinica Correlations
581
Tumor-associated Antigen Production Is Increased In Systemic Sclerosis And May Be Associated With Kidney Involvement And Markers Of Inflammation
See more of: ACR Abstract Submission Poster Sessions
<< Previous Session Level | Next Session Level >>